Metraipolis › archive › dc_2c40ce4ed4f3

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer — Europe PMC PMID:41171165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41171165
DOI
10.1158/2767-9764.crc-25-0332
License (as archived)
solo-consultazione
Archived
2026-11-08T21:41:24.782Z
SHA-256 of the archived text
5706faba8f93a7e7035427f7f2e7519a5878998ecc5ce7f8c49a3749658ad51e
Stable URL of this page
https://metraipolis.com/documento/dc_2c40ce4ed4f3

How to cite

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer — Europe PMC PMID:41171165 — Europe PMC (en), https://europepmc.org/article/MED/41171165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c40ce4ed4f3 (Metraipolis archive dc_2c40ce4ed4f3, sha256 5706faba8f93a7e7035427f7f2e7519a5878998ecc5ce7f8c49a3749658ad51e)
BibTeX
@misc{dc2c40ce4ed4f3,
  title = {Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer — Europe PMC PMID:41171165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41171165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c40ce4ed4f3; sha256 5706faba8f93a7e7035427f7f2e7519a5878998ecc5ce7f8c49a3749658ad51e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41171165. Agents can read the archived copy with the MCP tool read_document.